HSHans-Ulrich Steinau

Hans-Ulrich Steinau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hans-Ulrich Steinau has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5

    by Matthias Schulte, Michael Sorkin, Sammy Al-Benna, Jadwiga Stupka, Tobias Hirsch, Adrien Daigeler, Marco Rainer Kesting, Hans-Ulrich Steinau, Frank Jacobsen, Lars Steinstraesser

    Methods for human skin gene therapy requires efficient and stable introduction of genes into skin cells. Transient cutaneous gene therapy is an attractive approach in the treatment of skin diseases. The ‘Achilles heel’ of adenoviral gene therapy is its immunogenicity and many aspects of adenovirus induced cutaneous immune reaction still remain unanswered, particularly the role of keratinocytes. Therefore, human keratinocytes were transfected with adenoviral DNA and cytokine expression was analyzed. Moreover, adenoviral transduction of full-skin was performed ex vivo and in vivo. We observed cytokine induction after cytoplasmatic internalization of adenoviral DNA into epidermal cells. Inhibition of AIM2, NALP3, DAI or mda5 downregulated the cytokine response. Transduction of immunocompetent mice led to a detectable transgene expression for 12 days. Re-application of the vector led to a decrease in intensity and duration of transgene expression limited to 4 days and an increased cytokine expression. In contrast, immunodeficient mice showed a reduced expression of cytokines after DNA internalization. AIM2, NALP3, DAI and mda5 are essential in the induction of an innate immune response towards adenoviral DNA. This immune reaction leads to a decrease in transduction efficiency of the vector after re-application and modulation of these receptor systems stabilizes transgene expression.


  • LOP28

    by B. Merwart, S. Al-Benna, M. Becerikli, P. Suppelna, M. Lam, A. Rittig, H.-U. Steinau, F. Jacobsen, L. Steinstraesser

  • LOP44

    by M. Becerikli, R. Tsoukas, W. Koehne, F. Jacobsen, A. Rittig, C. Theiss, S. Al-Benna, H.-U. Steinau, L. Steinstraesser

  • LOP29

    by P. Suppelna, S. Al-Benna, B. Merwart, M. Becerikli, A. Rittig, H.-U. Steinau, F. Jacobsen, L. Steinstraesser

  • Bösartige Weichgewebsgeschwülste

    by Dr. H.U. Steinau, L. Steinsträsser, J. Hauser, D. Tilkorn, I. Stricker, A. Daigeler

    Die operative Entfernung mit einem Sicherheitsabstand von 1–2 cm stellt die Basis der multidisziplinären Versorgung von Weichgewebssarkomen des Rumpfes und der Extremitäten dar. Bei Tumoren mit hoher biologischer Aktivität (Grading 2/3) ist die perioperative Radiatio/Chemotherapie unter Studienbedingungen indiziert. Für periphere Lokalisationen oder Komplikationen werden im Tumorboard zusätzliche Möglichkeiten wie die hypertherme Perfusion mit Tumornekrosefaktor α oder das gesamte Spektrum der plastischen Wiederherstellung einbezogen. Grundsätzlich sollten Patienten mit Weichgewebssarkomen in „high volume“-Zentren versorgt werden. Adequate surgical removal of soft tissue sarcomas of the trunk and extremities employing safety margins of 1–2 cm is the accepted basis of multidisciplinary treatment. In cases of high risk tumors (grades G2/G3) the tumor board decision should include radiochemotherapy under study conditions. Difficult peripheral locations or perioperative complications require additional techniques, such as hyperthermic perfusion with tumor necrosis factor alpha or the complete spectrum of reconstructive plastic procedures. Patients with soft tissue sarcoma of the trunk or of the extremities should always be referred to high volume centers.


  • Bösartige Weichgewebsgeschwülste

    by Dr. H.U. Steinau, L. Steinsträsser, J. Hauser, D. Tilkorn, I. Stricker, A. Daigeler

    Die operative Entfernung mit einem Sicherheitsabstand von 1–2 cm stellt die Basis der multidisziplinären Versorgung von Weichgewebssarkomen des Rumpfes und der Extremitäten dar. Bei Tumoren mit hoher biologischer Aktivität (Grading 2/3) ist die perioperative Radiatio/Chemotherapie unter Studienbedingungen indiziert. Für periphere Lokalisationen oder Komplikationen werden im Tumorboard zusätzliche Möglichkeiten wie die hypertherme Perfusion mit Tumornekrosefaktor α oder das gesamte Spektrum der plastischen Wiederherstellung einbezogen. Grundsätzlich sollten Patienten mit Weichgewebssarkomen in „high volume“-Zentren versorgt werden. Adequate surgical removal of soft tissue sarcomas of the trunk and extremities employing safety margins of 1–2 cm is the accepted basis of multidisciplinary treatment. In cases of high risk tumors (grades G2/G3) the tumor board decision should include radiochemotherapy under study conditions. Difficult peripheral locations or perioperative complications require additional techniques, such as hyperthermic perfusion with tumor necrosis factor alpha or the complete spectrum of reconstructive plastic procedures. Patients with soft tissue sarcoma of the trunk or of the extremities should always be referred to high volume centers.


  • LOP31: ROLE OF EPHRIN-B4 IN WOUND REPAIR

    by R.L. Tsoukas, M. Becerikli, F. Jacobsen, B.D. Mikhail, M. Schulte, I. Stricker, A. Rittig, H.-U. Steinau, L. Steinstraesser

  • Open Access

    Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery

    by Lars Steinstraesser, Michael Sorkin, Frank Jacobsen, Sammy Al-Benna, Marco Rainer Kesting, Andreas David Niederbichler, Jan-Michel Otte, Tobias Hirsch, Jadwiga Stupka, Hans-Ulrich Steinau, et al.

    Background: Adenoviral vectors have provided effective methods for in vivo gene delivery in therapeutic applications. However, these vectors can induce immune responses that may severely affect the ability of vector re-application. There is limited information about the mechanisms and signal transduction pathways involved in adenoviral recognition. For optimization of cutaneous gene therapy it is necessary to investigate molecular mechanisms of virus recognition in epidermal cells. The aim of this study was to investigate the signal transduction of the innate immunity after adenoviral DNA internalization in keratinocytes. Methods: In vitro, keratinocytes were transfected with DNA, in the presence and absence of inhibitors for signalling molecules. In vivo, immunocompetent and athymic mice (n = 3 per group) were twice transduced with an Ad-vector. Results: The results show an acute induction of type-I-interferon after in vitro transfection. Inhibition of PI3K, p38 MAPK, JNK and NFkappaB resulted in a decreased expression of type-I-interferon. In contrast to immunocompetent mice, athymic mice demonstrated a constant transgene expression and reduced inflammatory response in vivo. Conclusion: The results suggest an induction of the innate immunity triggered by cytoplasm localised DNA which is mediated by PI3K-, p38 MAPK-, JNK-, NFkappaB-, JAK/STAT- and ERK1/2-dependent pathways. A stable transgene expression and a reduced inflammatory response in immunodeficient mice have been observed. These results provide potential for an effective adenoviral gene delivery into immunosupressed skin.


  • Tendon transfers for drop foot correction: long-term results including quality of life assessment, and dynamometric and pedobarographic measurements

    by Hans-Ulrich Steinau, Alexandra Tofaute, Kathrin Huellmann, Ole Goertz, Marcus Lehnhardt, Jessica Kammler, Lars Steinstraesser, Adrien Daigeler

    Background Drop foot deformity is a common problem with severe restrictions in quality of life and impairment of daily activities. A technique of posterior tibial tendon transfer through the interosseus membrane and fixation to the anterior tibial and the long peroneal tendon “Bridle procedure” (stirrup-plasty) offers a physiological alternative to surgical correction. Methods Data of 53 consecutive patients treated by stirrup-plasty were acquired from patient’s charts; 31 were interviewed with standardized questionnaires; 20 were examined physically; 19 received pedobarography, and 8 underwent dynamometric muscle function tests. Follow-up time averaged 6.5 years. Results The mean range of motion (ROM) in the ankle joint was 8° dorsiflexion and 15° plantar flexion. Most patients achieved plantigrade foot position and the majority developed gait without orthotic devices. As expected, maximum dorsiflexion torque averaged a third of the non-operated leg, according to reduced muscle diameter and strength of the transferred muscle. Pressure distribution of the sole during gait was not relevantly altered by the tendon transfer compared to the non-operated leg. Most patients were satisfied with the operative results and reported a significant increase in quality of life. Conclusions Fusion of the transposed posterior tibial, anterior tibial and the peroneus longus tendon prevents drop foot deformity sufficiently. The stirrup mechanism, in combination with tenodesis of the toe extensors, provides a balanced foot and avoids equinovarus and cavus deformity without immobilizing the ankle joint. Improvements in quality of life parameters justify the risk of the operative procedure for the patient.


  • Resektionsgrenzen bei Weichgewebssarkomen der Extremitäten

    by H.-U. Steinau, L. Steinsträsser, S. Langer, I. Stricker, O. Goertz

    Negative surgical margins (R0 resection) play a key role in the prevention of local recurrences of soft tissue sarcoma of the extremities in the multimodal therapy concept. The prognostic relevance for long-term survival is still under dispute. Despite the fact that numerous recommendations and guidelines have existed for over 100 years, strong evidence-based data from prospective randomized studies are still not available today. These studies should include parameters like tumor localization, subtype and biological aggressiveness. Recommendations as to surgical therapy diverge considerably. They range from amputation and compartment resection to centimetre and millimetre surgical margins. The present article analyses currently available data and definitions and discusses the impact on functional restriction, lymph drainage, local recurrence and the perioperative irradiation field. In the absence of surgical standards, it is doubtful whether existing studies and multicenter trials currently underway are valid. Close co-operation between surgeon and pathologist is imperative to further substantiate the significance of histological examinations and resection margins.